Article info
PDFClinical science
Infliximab for the treatment of refractory scleritis
- Correspondence to Dr C Stephen Foster, Massachusetts Eye Research and Surgery Institution, 5 Cambridge Center, Cambridge, MA 02142, USA; sfoster{at}mersi.us
Citation
Infliximab for the treatment of refractory scleritis
Publication history
- Accepted September 30, 2009
- First published December 2, 2009.
Online issue publication
July 30, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.